Results 211 to 220 of about 2,076,755 (337)

Hospital visits among women with skeletal-related events secondary to breast cancer and bone metastases: a nationwide population-based cohort study in Denmark

, 2013
Henrik Gammelager, Svendsen, Claus Sværke, Yong, Victoria M. Chia, Christian Fynbo Christiansen, Fryzek   +6 more
openalex   +2 more sources

Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases [PDF]

, 2019
Hirotsugu Uemura, Hiroji Uemura, Satsohi Nagamori, Yoshiaki Wakumoto, Go Kimura, Hiroaki Kikukawa, Akira Yokomizo, Atsushi Mizokami, Takeo Kosaka, Naoya Masumori, Yoshihide Kawasaki, Junji Yonese, Yasutomo Nasu, Satoshi Fukasawa, Takayuki Sugiyama, Seigo Kinuya, Makoto Hosono, Iku Yamaguchi, Takashi Akagawa, Nobuaki Matsubara   +19 more
openalex   +1 more source

CXC Chemokine‐Driven Vascular Reprogramming: Modulating Tumor Vasculature to Boost Therapeutic Response

Advanced Science, EarlyView.
Tumor vascular remodeling is discussed from a chemokine‐centered perspective. This review summarizes the bidirectional, temporal, and tissue‐specific roles of CXC chemokines in regulating vascular function and immune accessibility. A functional vascular normalization score is introduced as a conceptual framework to integrate dynamic vascular and immune
Hongdan Chen, Yinde Huang, Juntong Wu, Ziying Yi, Yao Li, Zeyu Yang, Fan Zhang, Chong Li   +7 more
wiley   +1 more source

Impact on symptoms and survival of bone metastases in patients with small-intestinal neuroendocrine tumours. [PDF]

J Neuroendocrinol
Wedin M, Janson ET, Wallin G, Sundin A, Daskalakis K.   +4 more
europepmc   +1 more source

Cholesterol Promotes Lung Adenocarcinoma Brain Metastasis by Stabilizing EGFR Protein to Drive EMT, Metabolic Reprogramming, and Premetastatic Niche Formation

Advanced Science, EarlyView.
Cholesterol is revealed as a multitasking fuel for lung adenocarcinoma brain metastasis: it locks EGFR at the membrane to sustain AKT/NF‐κB–driven glycolysis and EMT, loosens the blood–brain barrier by promoting Claudin‐5 loss, and rewires microglia through IL‐4R lipid‐raft–JAK1/STAT6 signaling.
Ying Chen, Xiaoteng Cui, Xinyi Shi, Xu Yang, Yujing Cao, Haolin LI, Qi Zhan, Qixue Wang, Ang Li, Qihong Cheng, Yunfei Wang, Junhu Zhou, MingJie Wang, Chunsheng Kang, Xiaomin Liu   +14 more
wiley   +1 more source

Real-life use of bone-targeting agents for bone metastases in France between 2009 and 2018: Results of the OPTIMOS study. [PDF]

J Bone Oncol
Confavreux CB, Bouvard B, Girard N, Bosco-Levy P, Marchal C, Nolin M, Lehmann E, Desameric G, Belhassen M.   +8 more
europepmc   +1 more source

Survival prediction nomogram for patients with vertebral bone metastases treated with palliative radiotherapy

, 2023
Kazuya Takeda, Rei Umezawa, Takaya Yamamoto, Noriyoshi Takahashi, Yu Suzuki, Keita Kishida, So Omata, Keiichi Jingu   +7 more
openalex   +2 more sources

Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline.

Practical Radiation Oncology, 2017
S. Lutz, T. Balboni, Joshua Jones, S. Lo, J. Petit, S. Rich, R. Wong, C. Hahn   +7 more
semanticscholar   +1 more source

Combination of Ethoxybenzyl‐Diethylenetriamine Pentaacetic Acid‐Enhanced Magnetic Resonance Imaging and a Serum Biomarker Is Useful in the Diagnosis of Hepatic Sinusoidal Disorder After Chemotherapy Treatment

Annals of Gastroenterological Surgery, EarlyView.
ROC analyses of APRI score, EOB‐MRI, and a combination of EOB‐MRI and APRI score for blue liver. ABSTRACT Aim Sinusoidal obstruction syndrome (SOS), also known as “blue liver (BL),” is a common hepatic injury following oxaliplatin‐based chemotherapy in patients with colorectal liver metastases (CRLM).
Tomonari Shimagaki, Keishi Sugimachi, Takahiro Tomino, Takeshi Kurihara, Emi Onishi, Yutaro Shimomura, Kenji Shinozaki, Masaru Morita   +7 more
wiley   +1 more source

Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and management. [PDF]

J Neuroendocrinol
Fazio N, Maisonneuve P, Frezza AM, Ranallo N, Ibrahim T, La Salvia A, Brizzi MP, De Divitiis C, Tafuto S, Pusceddu S, Marconcini R, Cives M, Ferrari C, Campana D, De Lisi D, Santini D, Faggiano A, Modica R, Massironi S, Bianchi A, Panzuto F, Antonuzzo L, Pellegrini E, Amoroso V, Puliafito I, Merola E, Silvestris N, Grana CM, Spada F.   +28 more
europepmc   +1 more source